BIO-RAD LABORATORIES, INC. — Director's Dealing 2021

Apr 9, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO BIOB)
CIK: 0000012208
Period of Report: 2021-04-08

Reporting Person: Daskal Ilan (EVP, Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-04-08	Bio-Rad A Common Stock	M	700	—	Acquired	1157	Direct
2021-04-08	Bio-Rad A Common Stock	F	250	$592.23	Disposed	907	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-08	Restricted Stock Units	$0	M	700	Disposed		Bio-Rad A Common Stock (700)	Direct

Footnotes

F1: Shares of Class A common stock acquired on the vesting of restricted stock units.

F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F3: On April 8, 2019, the reporting person was granted 3,500 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.